Related Experiment Video
Updated: Aug 19, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Tests for treatment group differences in the hazards for survival, before and after the occurrence of an intermediate
Judith D Bebchuk1, Rebecca A Betensky
1University of Minnesota Division of Biostatistics, Minneapolis, MN 55414, USA. judyb@ccbr.umn.edu
Abstract:
In many settings, one would expect that the hazard for a terminal event would change with the occurrence of an intermediate event. For example, in an AIDS clinical trial, it is of interest to assess whether there is a difference between treatments in the hazards for death prior to drop in Karnofsky performance score and in the hazards subsequent to the drop in Karnofsky score. Tests for the effect of treatment on these hazard functions, separately or jointly, are useful in conjunction with tests of overall survival. We consider four Cox regression models for the hazard function, constructed by allowing for various combinations of time-dependent stratification and time-dependent covariates, both of which are based on the occurrence of the intermediate event. Assuming a Markov transition model from the intermediate to the terminal event, partial likelihoods can be used for inference, enabling the use of standard statistical software for computation. We develop analytic approximations for the power of the derived score tests for treatment differences in the hazard functions and evaluate them through simulations. We apply our results to AIDS Clinical Trials Group (ACTG) protocol 021.
Related Concept Videos
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time until a...
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Assumptions of Survival Analysis
Comparing the Survival Analysis of Two or More Groups
The Mantel-Cox Log-Rank Test
Hazard Ratio
For example, in a clinical trial evaluating a...

